Picture of BELLUS Health logo

BLU BELLUS Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Bellus Health Inc Reports Results For The Quarter Ended In September: Earnings Summary

* BELLUS Health Inc  BLU.TO  reported a quarterly adjusted
loss
of 20 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 16 cents per share.
    * Revenue held steady 0% to $4.00 thousand from a year ago;
analysts expected $3.50 thousand. 
    * BELLUS Health Inc's reported EPS for the quarter was a
loss
of 20 cents​.
    * The mean earnings estimate of analysts had risen by
about 10% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * BELLUS Health Inc shares had fallen by 17.4% this
quarter and
gained 18.5% so far this year.
    * The company reported a quarterly loss of $24.71 million.
    * Wall Street's median 12-month price target for BELLUS
Health Inc
is C$22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.16          -0.20          Missed
 Jun. 30 2022      -0.17          -0.18          Missed
 Mar. 31 2022      -0.20          -0.13          Beat
 Dec. 31 2021      -0.22          -0.18          Beat

Recent news on BELLUS Health

See all news